{"protocolSection": {"identificationModule": {"nctId": "NCT03406325", "orgStudyIdInfo": {"id": "REC-2017-17"}, "organization": {"fullName": "Hong Kong Sanatorium & Hospital", "class": "INDUSTRY"}, "briefTitle": "Mast Cell Activation Test in Allergic Disease", "officialTitle": "Assessment of Mast Cell Activation Diagnostic Test in Patients With Allergic Disease"}, "statusModule": {"statusVerifiedDate": "2020-03", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2018-02-01", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2019-12-01", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-12-01", "type": "ACTUAL"}, "studyFirstSubmitDate": "2018-01-14", "studyFirstSubmitQcDate": "2018-01-14", "studyFirstPostDateStruct": {"date": "2018-01-23", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2020-02-10", "resultsFirstSubmitQcDate": "2020-03-27", "resultsFirstPostDateStruct": {"date": "2020-04-09", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2020-03-27", "lastUpdatePostDateStruct": {"date": "2020-04-09", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Lee Tak Hong", "investigatorTitle": "Director Allergy Centre", "investigatorAffiliation": "Hong Kong Sanatorium & Hospital"}, "leadSponsor": {"name": "Hong Kong Sanatorium & Hospital", "class": "INDUSTRY"}, "collaborators": [{"name": "Chinese University of Hong Kong", "class": "OTHER"}, {"name": "Stanford University", "class": "OTHER"}]}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "Activation of mast cells in the immune system is known to cause allergic reactions sometimes with severe systemic symptoms. The investigators have recently developed a blood-based mast cell activation diagnostic test in which levels of functional activation in-vitro in primary cultured mast cells generated from the peripheral blood of single individuals can be assessed. It is the hypothesis that the test can be used to predict the potential state of in-vivo mast cell activation in any individual based on the functional activation profiles exhibited by their cultured mast cells. The investigators now wish to translate their in-vitro findings in a pilot study to disease groups where mast cell activation is expected to be high. These include highly allergic individuals; those with chronic idiopathic urticaria; those with mastocytosis; and those with the mast cell activation syndrome. Furthermore, they will use the functional genomics approach to identify gene expression biomarkers that are correlated with such diseases. The results will be compared with data that have been collected from a cohort of healthy control blood donors.", "detailedDescription": "The objective of this study is to assess whether patients with severe allergic diseases exhibit high levels of mast cell activation as determined by the mast cell activation diagnostic test the investigators have developed. They anticipate that patients with history of severe allergic reactions will show up as high responders in the blood-based mast cell activation diagnostic test. Moreover, using microarray analysis as the approach for gene expression studies, they anticipate further that genomics biomarkers that are correlated with the high functional activation of the in-vitro mast cells derived from these patients can be readily identified.\n\nAbout 100 ml of peripheral venous blood from individual patients will be drawn into heparinized syringes and collected in a blood-collecting bag/tube containing silica. The bag/tube will be promptly processed for the generation of primary human mast cell cultures using the protocol that has previously been developed \\[Inflammation Research 66: 25 (2017). After culturing for 9 weeks, the resulting human mast cells will be analyzed for both their functional activity in terms of histamine release in response to the activation of high-affinity Immunoglobulin E (IgE) receptors in these cells and their gene expression profiles using microarray analysis. The in-vitro functional and genomics data will be correlated with specific diagnoses and measurements of blood prostaglandin D2 (PGD2), PGD2 metabolites, tryptase and histamine levels in blood. For mediator assays, plasma from each subject will be collected after the cluster of differentiation 34 positive (CD34+) isolation step and the samples will be aliquoted and frozen at -80 degrees centigrade for subsequent analysis."}, "conditionsModule": {"conditions": ["Asthma", "Mastocytosis", "Mast Cell Activation Syndrome", "Food Allergy", "Chronic Idiopathic Urticaria", "Anaphylaxis", "Eczema"], "keywords": ["mast cell", "allergy", "genomic", "biomarkers"]}, "designModule": {"studyType": "OBSERVATIONAL", "patientRegistry": false, "designInfo": {"observationalModel": "COHORT", "timePerspective": "CROSS_SECTIONAL"}, "bioSpec": {"retention": "SAMPLES_WITHOUT_DNA", "description": "blood samples for mediator measurements"}, "enrollmentInfo": {"count": 19, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "urticaria", "description": "Patients with this condition"}, {"label": "asthma", "description": "Patients with this condition"}, {"label": "eczema", "description": "Patients with this condition"}, {"label": "food allergy", "description": "Patients with this condition"}, {"label": "anaphylaxis", "description": "Patients with this condition"}, {"label": "mastocytosis", "description": "Patients with this condition"}, {"label": "mast cell activating syndrome", "description": "Patients with this condition"}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Mast Cell Activation Test Results for Validation Group", "description": "Mast Cell Activation Test results of high/low level of house dust mite sensitivity by using normal donor cultured mast cells for validation.", "timeFrame": "Mast cells studied after 9 weeks in culture"}, {"measure": "Evaluation of Patient's Serum for Autoreactivity on Normal Average Responder Mast Cell Activation", "description": "Patient's serum was incubated with mast cells derived from normal donors for detection of mast cell activation as evidenced by histamine release.", "timeFrame": "Mast cells studied after 9 weeks in culture"}, {"measure": "Percentage Histamine Release by Normal Average Responder Mast Cells + Patient's Serum to Assess Autoreactivity", "description": "percentage of total histamine release by normal average responder mast cells that had been activated with patient's serum", "timeFrame": "Mast cells studied after 9 weeks in culture"}, {"measure": "Percentage Histamine Release by Patient's Mast Cells + Immunoglobulin E (IgE)/Anti-IgE", "description": "percentage of total histamine release by patient's mast cells that had been activated with anti-IgE", "timeFrame": "Mast cells studied after 9 weeks in culture"}, {"measure": "Percentage of Histamine Release by Patient's Mast Cells + Patient's Serum + Allergen", "description": "Percentage of total histamine release when patient's mast cells were activated with patient's own serum and Der p2. Each patient's results are reported individually.", "timeFrame": "Mast cells studied after 9 weeks in culture"}, {"measure": "Cell Yield Per 100ml Blood", "description": "Cell yield of patient's mast cell culture after 9 weeks in culture as an index of cell growth and differentiation.", "timeFrame": "Mast cells studied after 9 weeks in culture"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\nAny patients with the above diagnoses -\n\nExclusion Criteria:\n\nChildren \\< 18 years old; those who are unwilling or unable to donate blood; pregnant mothers.\n\n-", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"], "studyPopulation": "Highly allergic individuals", "samplingMethod": "NON_PROBABILITY_SAMPLE"}, "contactsLocationsModule": {"overallOfficials": [{"name": "Tak H Lee", "affiliation": "Hong Kong Sanatorium and Hospital", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Hong Kong Sanatorium & Hospital", "city": "Hong Kong", "country": "Hong Kong", "geoPoint": {"lat": 22.27832, "lon": 114.17469}}]}, "referencesModule": {"references": [{"pmid": "27628164", "type": "BACKGROUND", "citation": "Tam IYS, Ng CW, Tam SY, Lau HYA. Novel six-week protocol for generating functional human connective tissue-type (MCTC) mast cells from buffy coats. Inflamm Res. 2017 Jan;66(1):25-37. doi: 10.1007/s00011-016-0989-z. Epub 2016 Sep 15. Erratum In: Inflamm Res. 2017 Nov 13;:"}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "19 patients were recruited in the study. 12 were used for validation. 7 were used for patient-specific testing. Therefore, there were 1 validation group and 7 individuals' result.", "groups": [{"id": "FG000", "title": "Validation Group", "description": "Mast cell activation test employing normal donor cultured mast cells and allergic patient serum samples"}, {"id": "FG001", "title": "SH#1", "description": "Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema"}, {"id": "FG002", "title": "SH#2", "description": "Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema"}, {"id": "FG003", "title": "SH#3", "description": "Female patient, Total IgE: 5333KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema"}, {"id": "FG004", "title": "SH#4", "description": "Male patient, Total IgE: 4070KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema, Urticaria"}, {"id": "FG005", "title": "SH#5", "description": "Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis"}, {"id": "FG006", "title": "SH#6", "description": "Female patient, Total IgE: 13KU/L; Der p2IgE: \\<0.1KU/L; clinical diagnosis: Mast cell activation syndrome"}, {"id": "FG007", "title": "SH#7", "description": "Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "12"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "1"}, {"groupId": "FG005", "numSubjects": "1"}, {"groupId": "FG006", "numSubjects": "1"}, {"groupId": "FG007", "numSubjects": "1"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "12"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "1"}, {"groupId": "FG005", "numSubjects": "1"}, {"groupId": "FG006", "numSubjects": "1"}, {"groupId": "FG007", "numSubjects": "1"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "During recruitment period, no participants with asthma, food allergy, mastocytosis were recruited.", "groups": [{"id": "BG000", "title": "Validation Group", "description": "Mast cell activation test employing normal donor cultured mast cells and allergic patient serum samples"}, {"id": "BG001", "title": "SH#1", "description": "Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema"}, {"id": "BG002", "title": "SH#2", "description": "Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema"}, {"id": "BG003", "title": "SH#3", "description": "Female patient, Total IgE: 5333KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema"}, {"id": "BG004", "title": "SH#4", "description": "Male patient, Total IgE: 4070KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema, Urticaria"}, {"id": "BG005", "title": "SH#5", "description": "Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis"}, {"id": "BG006", "title": "SH#6", "description": "Female patient, Total IgE: 13KU/L; Der p2IgE: \\<0.1KU/L; clinical diagnosis: Mast cell activation syndrome"}, {"id": "BG007", "title": "SH#7", "description": "Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria"}, {"id": "BG008", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}, {"groupId": "BG003", "value": "1"}, {"groupId": "BG004", "value": "1"}, {"groupId": "BG005", "value": "1"}, {"groupId": "BG006", "value": "1"}, {"groupId": "BG007", "value": "1"}, {"groupId": "BG008", "value": "19"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}, {"groupId": "BG003", "value": "1"}, {"groupId": "BG004", "value": "1"}, {"groupId": "BG005", "value": "1"}, {"groupId": "BG006", "value": "1"}, {"groupId": "BG007", "value": "1"}, {"groupId": "BG008", "value": "19"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "0"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "1"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "1"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "11"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "1"}, {"groupId": "BG005", "value": "1"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "1"}, {"groupId": "BG008", "value": "8"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}, {"groupId": "BG003", "value": "1"}, {"groupId": "BG004", "value": "1"}, {"groupId": "BG005", "value": "1"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "1"}, {"groupId": "BG008", "value": "18"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "0"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "1"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "1"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Hong Kong", "categories": [{"measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}, {"groupId": "BG003", "value": "1"}, {"groupId": "BG004", "value": "1"}, {"groupId": "BG005", "value": "1"}, {"groupId": "BG006", "value": "1"}, {"groupId": "BG007", "value": "1"}, {"groupId": "BG008", "value": "7"}]}]}]}, {"title": "Clinical diagnosis", "description": "Clinical diagnosis of participants before Mast cell activation test", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Eczema", "measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}, {"groupId": "BG003", "value": "1"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "7"}]}, {"title": "Rhinitis", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "5"}]}, {"title": "Urticaria", "measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "1"}, {"groupId": "BG008", "value": "4"}]}, {"title": "Exercise-induced anaphylaxis", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "1"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "1"}]}, {"title": "Mast cell activation syndrome", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "1"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "1"}]}, {"title": "Eczema and Urticaria", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "1"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "1"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Mast Cell Activation Test Results for Validation Group", "description": "Mast Cell Activation Test results of high/low level of house dust mite sensitivity by using normal donor cultured mast cells for validation.", "populationDescription": "Mast cells were cultured from blood of normal donors to validate the (Mast Cell Activation) MAT assay. The serum samples were obtained from allergic patients with sensitivities to Der p2 and used for passive sensitization of normal donor mast cells followed by their activation by Der p2 allergen. Data were collected only from the validation group.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Mast cells studied after 9 weeks in culture", "groups": [{"id": "OG000", "title": "Validation Group", "description": "Mast cell activation test employing normal donor cultured mast cells and allergic patient serum samples"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}]}], "classes": [{"title": "High level of house dust mite sensitivity", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "8"}]}], "categories": [{"title": "MAT positive", "measurements": [{"groupId": "OG000", "value": "6"}]}, {"title": "MAT negative", "measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Low level of house dust mite sensitivity", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "4"}]}], "categories": [{"title": "MAT positive", "measurements": [{"groupId": "OG000", "value": "0"}]}, {"title": "MAT negative", "measurements": [{"groupId": "OG000", "value": "4"}]}]}]}, {"type": "PRIMARY", "title": "Evaluation of Patient's Serum for Autoreactivity on Normal Average Responder Mast Cell Activation", "description": "Patient's serum was incubated with mast cells derived from normal donors for detection of mast cell activation as evidenced by histamine release.", "populationDescription": "Serum samples were obtained from 19 patients in total, of whom 12 were in the validation group. The other 7 patients were studied more extensively in the trial and their data is reported individually in this section and thereafter.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Mast cells studied after 9 weeks in culture", "groups": [{"id": "OG000", "title": "Validation Group", "description": "Mast cell activation test employing normal donor cultured mast cells and allergic patient serum samples"}, {"id": "OG001", "title": "SH#1", "description": "Male patient, Total IgE: 28918 KU/L; Der p2 IgE: 64.4 KU/L; clinical diagnosis: Eczema"}, {"id": "OG002", "title": "SH#2", "description": "Male patient, Total IgE: 22311 KU/L; Der p2 IgE: 91.24 KU/L; clinical diagnosis: Eczema"}, {"id": "OG003", "title": "SH#3", "description": "Female patient, Total IgE: 5333 KU/L; Der p2 IgE: \\>100 KU/L; clinical diagnosis: Eczema"}, {"id": "OG004", "title": "SH#4", "description": "Male patient, Total IgE: 4070 KU/L; Der p2 IgE: \\>100 KU/L; clinical diagnosis: Eczema, Urticaria"}, {"id": "OG005", "title": "SH#5", "description": "Male patient, Total IgE: 379 KU/L; Der p2 IgE: 0.15 KU/L; clinical diagnosis: Exercise-induced anaphylaxis"}, {"id": "OG006", "title": "SH#6", "description": "Female patient, Total IgE: 13 KU/L; Der p2 IgE: \\<0.1 KU/L; clinical diagnosis: Mast cell activation syndrome"}, {"id": "OG007", "title": "SH#7", "description": "Male patient, Total IgE: 67 KU/L; Der p2 IgE: None KiloUnits (KU)/L; clinical diagnosis: Urticaria"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "1"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "1"}, {"groupId": "OG006", "value": "1"}, {"groupId": "OG007", "value": "1"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Percentage Histamine Release by Normal Average Responder Mast Cells + Patient's Serum to Assess Autoreactivity", "description": "percentage of total histamine release by normal average responder mast cells that had been activated with patient's serum", "populationDescription": "Mast cells derived from the validation group is reported as a group (mean +/-SD). The other 7 allergic patients were analysed and reported individually as explained earlier.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage of histamine released", "timeFrame": "Mast cells studied after 9 weeks in culture", "groups": [{"id": "OG000", "title": "Validation Group", "description": "Mast cell activation test employing normal donor cultured mast cells and allergic patient serum samples"}, {"id": "OG001", "title": "SH#1", "description": "Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema"}, {"id": "OG002", "title": "SH#2", "description": "Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema"}, {"id": "OG003", "title": "SH#3", "description": "Female patient, Total IgE: 5333KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema"}, {"id": "OG004", "title": "SH#4", "description": "Male patient, Total IgE: 4070KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema, Urticaria"}, {"id": "OG005", "title": "SH#5", "description": "Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis"}, {"id": "OG006", "title": "SH#6", "description": "Female patient, Total IgE: 13KU/L; Der p2IgE: \\<0.1KU/L; clinical diagnosis: Mast cell activation syndrome"}, {"id": "OG007", "title": "SH#7", "description": "Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "1"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "1"}, {"groupId": "OG006", "value": "1"}, {"groupId": "OG007", "value": "1"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.15", "spread": "0.71"}, {"groupId": "OG001", "value": "32.1"}, {"groupId": "OG002", "value": "3.3"}, {"groupId": "OG003", "value": "2.8"}, {"groupId": "OG004", "value": "3.4"}, {"groupId": "OG005", "value": "5.1"}, {"groupId": "OG006", "value": "3.2"}, {"groupId": "OG007", "value": "3.8"}]}]}]}, {"type": "PRIMARY", "title": "Percentage Histamine Release by Patient's Mast Cells + Immunoglobulin E (IgE)/Anti-IgE", "description": "percentage of total histamine release by patient's mast cells that had been activated with anti-IgE", "populationDescription": "Mast cells derived from 7 allergic patients were analysed and reported individually. Patients in the validation group were not measured for this outcome and their samples were only used to validate the assay.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of histamine release", "timeFrame": "Mast cells studied after 9 weeks in culture", "groups": [{"id": "OG000", "title": "SH#1", "description": "Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema"}, {"id": "OG001", "title": "SH#2", "description": "Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema"}, {"id": "OG002", "title": "SH#3", "description": "Female patient, Total IgE: 5333KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema"}, {"id": "OG003", "title": "SH#4", "description": "Male patient, Total IgE: 4070KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema, Urticaria"}, {"id": "OG004", "title": "SH#5", "description": "Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis"}, {"id": "OG005", "title": "SH#6", "description": "Female patient, Total IgE: 13KU/L; Der p2IgE: \\<0.1KU/L; clinical diagnosis: Mast cell activation syndrome"}, {"id": "OG006", "title": "SH#7", "description": "Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "1"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "1"}, {"groupId": "OG006", "value": "1"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "11.5"}, {"groupId": "OG001", "value": "38.3"}, {"groupId": "OG002", "value": "69.6"}, {"groupId": "OG003", "value": "47.9"}, {"groupId": "OG004", "value": "36.3"}, {"groupId": "OG005", "value": "45.5"}, {"groupId": "OG006", "value": "41.6"}]}]}]}, {"type": "PRIMARY", "title": "Percentage of Histamine Release by Patient's Mast Cells + Patient's Serum + Allergen", "description": "Percentage of total histamine release when patient's mast cells were activated with patient's own serum and Der p2. Each patient's results are reported individually.", "populationDescription": "Mast cells derived from 7 allergic patients were analysed and reported individually. Patients in the validation group were not measured for this outcome and their samples were only used to validate the assay.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of histamine release", "timeFrame": "Mast cells studied after 9 weeks in culture", "groups": [{"id": "OG000", "title": "SH#1", "description": "Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema"}, {"id": "OG001", "title": "SH#2", "description": "Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema"}, {"id": "OG002", "title": "SH#3", "description": "Female patient, Total IgE: 5333KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema"}, {"id": "OG003", "title": "SH#4", "description": "Male patient, Total IgE: 4070KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema, Urticaria"}, {"id": "OG004", "title": "SH#5", "description": "Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis"}, {"id": "OG005", "title": "SH#6", "description": "Female patient, Total IgE: 13KU/L; Der p2IgE: \\<0.1KU/L; clinical diagnosis: Mast cell activation syndrome"}, {"id": "OG006", "title": "SH#7", "description": "Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "1"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "1"}, {"groupId": "OG006", "value": "1"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "24.5"}, {"groupId": "OG001", "value": "54.7"}, {"groupId": "OG002", "value": "79"}, {"groupId": "OG003", "value": "8.4"}, {"groupId": "OG004", "value": "0.2"}, {"groupId": "OG005", "value": "0.2"}, {"groupId": "OG006", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Cell Yield Per 100ml Blood", "description": "Cell yield of patient's mast cell culture after 9 weeks in culture as an index of cell growth and differentiation.", "populationDescription": "Mast cells derived from 7 allergic patients were analysed and reported individually. Patients in the validation group were not measured for this outcome and their samples were only used to validate the assay.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Cell yield per 100ml blood", "timeFrame": "Mast cells studied after 9 weeks in culture", "groups": [{"id": "OG000", "title": "SH#1", "description": "Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema"}, {"id": "OG001", "title": "SH#2", "description": "Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema"}, {"id": "OG002", "title": "SH#3", "description": "Female patient, Total IgE: 5333KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema"}, {"id": "OG003", "title": "SH#4", "description": "Male patient, Total IgE: 4070KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema, Urticaria"}, {"id": "OG004", "title": "SH#5", "description": "Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis"}, {"id": "OG005", "title": "SH#6", "description": "Female patient, Total IgE: 13KU/L; Der p2IgE: \\<0.1KU/L; clinical diagnosis: Mast cell activation syndrome"}, {"id": "OG006", "title": "SH#7", "description": "Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "1"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "1"}, {"groupId": "OG006", "value": "1"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "14045000"}, {"groupId": "OG001", "value": "2895522"}, {"groupId": "OG002", "value": "115294"}, {"groupId": "OG003", "value": "625263"}, {"groupId": "OG004", "value": "4867778"}, {"groupId": "OG005", "value": "352000"}, {"groupId": "OG006", "value": "1400000"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "18 months", "eventGroups": [{"id": "EG000", "title": "Validation Group", "description": "Mast cell activation test employing normal donor cultured mast cells and allergic patient serum samples", "deathsNumAffected": 0, "deathsNumAtRisk": 12, "seriousNumAffected": 0, "seriousNumAtRisk": 12, "otherNumAffected": 0, "otherNumAtRisk": 12}, {"id": "EG001", "title": "SH#1", "description": "Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema", "deathsNumAffected": 0, "deathsNumAtRisk": 1, "seriousNumAffected": 0, "seriousNumAtRisk": 1, "otherNumAffected": 0, "otherNumAtRisk": 1}, {"id": "EG002", "title": "SH#2", "description": "Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema", "deathsNumAffected": 0, "deathsNumAtRisk": 1, "seriousNumAffected": 0, "seriousNumAtRisk": 1, "otherNumAffected": 0, "otherNumAtRisk": 1}, {"id": "EG003", "title": "SH#3", "description": "Female patient, Total IgE: 5333KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema", "deathsNumAffected": 0, "deathsNumAtRisk": 1, "seriousNumAffected": 0, "seriousNumAtRisk": 1, "otherNumAffected": 0, "otherNumAtRisk": 1}, {"id": "EG004", "title": "SH#4", "description": "Male patient, Total IgE: 4070KU/L; Der p2IgE: \\>100KU/L; clinical diagnosis: Eczema, Urticaria", "deathsNumAffected": 0, "deathsNumAtRisk": 1, "seriousNumAffected": 0, "seriousNumAtRisk": 1, "otherNumAffected": 0, "otherNumAtRisk": 1}, {"id": "EG005", "title": "SH#5", "description": "Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis", "deathsNumAffected": 0, "deathsNumAtRisk": 1, "seriousNumAffected": 0, "seriousNumAtRisk": 1, "otherNumAffected": 0, "otherNumAtRisk": 1}, {"id": "EG006", "title": "SH#6", "description": "Female patient, Total IgE: 13KU/L; Der p2IgE: \\<0.1KU/L; clinical diagnosis: Mast cell activation syndrome", "deathsNumAffected": 0, "deathsNumAtRisk": 1, "seriousNumAffected": 0, "seriousNumAtRisk": 1, "otherNumAffected": 0, "otherNumAtRisk": 1}, {"id": "EG007", "title": "SH#7", "description": "Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria", "deathsNumAffected": 0, "deathsNumAtRisk": 1, "seriousNumAffected": 0, "seriousNumAtRisk": 1, "otherNumAffected": 0, "otherNumAtRisk": 1}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Prof. Tak Hong Lee", "organization": "Hong Kong Sanatorium & Hospital", "email": "TakHong.Lee@hksh.com", "phone": "28358430"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2017-11-21", "uploadDate": "2020-02-10T01:51", "filename": "Prot_SAP_000.pdf", "size": 391387}, {"typeAbbrev": "ICF", "hasProtocol": false, "hasSap": false, "hasIcf": true, "label": "Informed Consent Form", "date": "2017-11-01", "uploadDate": "2020-02-10T01:58", "filename": "ICF_001.pdf", "size": 130350}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000008415", "term": "Mastocytosis"}, {"id": "D000014581", "term": "Urticaria"}, {"id": "D000080223", "term": "Chronic Urticaria"}, {"id": "D000005512", "term": "Food Hypersensitivity"}, {"id": "D000000707", "term": "Anaphylaxis"}, {"id": "D000090267", "term": "Mast Cell Activation Syndrome"}], "ancestors": [{"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}, {"id": "D000012871", "term": "Skin Diseases"}, {"id": "D000017445", "term": "Skin Diseases, Vascular"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000009372", "term": "Neoplasms, Connective Tissue"}, {"id": "D000018204", "term": "Neoplasms, Connective and Soft Tissue"}, {"id": "D000009370", "term": "Neoplasms by Histologic Type"}, {"id": "D000009369", "term": "Neoplasms"}, {"id": "D000090362", "term": "Mast Cell Activation Disorders"}, {"id": "D000002908", "term": "Chronic Disease"}, {"id": "D000020969", "term": "Disease Attributes"}, {"id": "D000010335", "term": "Pathologic Processes"}], "browseLeaves": [{"id": "M16355", "name": "Syndrome", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "relevance": "LOW"}, {"id": "M7655", "name": "Eczema", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M8636", "name": "Food Hypersensitivity", "asFound": "Food Allergy", "relevance": "HIGH"}, {"id": "M11399", "name": "Mastocytosis", "asFound": "Mastocytosis", "relevance": "HIGH"}, {"id": "M17330", "name": "Urticaria", "asFound": "Urticaria", "relevance": "HIGH"}, {"id": "M4038", "name": "Anaphylaxis", "asFound": "Anaphylaxis", "relevance": "HIGH"}, {"id": "M2769", "name": "Mast Cell Activation Syndrome", "asFound": "Mast Cell Activation Syndrome", "relevance": "HIGH"}, {"id": "M2129", "name": "Chronic Urticaria", "asFound": "Chronic Idiopathic Urticaria", "relevance": "HIGH"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}, {"id": "M15674", "name": "Skin Diseases", "relevance": "LOW"}, {"id": "M19714", "name": "Skin Diseases, Vascular", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M12317", "name": "Neoplasms, Connective Tissue", "relevance": "LOW"}, {"id": "M20350", "name": "Neoplasms, Connective and Soft Tissue", "relevance": "LOW"}, {"id": "M12315", "name": "Neoplasms by Histologic Type", "relevance": "LOW"}, {"id": "M2776", "name": "Mast Cell Activation Disorders", "relevance": "LOW"}, {"id": "M6147", "name": "Chronic Disease", "relevance": "LOW"}, {"id": "M22700", "name": "Disease Attributes", "relevance": "LOW"}, {"id": "T1303", "name": "Chronic Graft Versus Host Disease", "relevance": "LOW"}, {"id": "T3626", "name": "Mastocytosis", "asFound": "Mastocytosis", "relevance": "HIGH"}, {"id": "T3624", "name": "Mast Cell Activation Syndrome", "asFound": "Mast Cell Activation Syndrome", "relevance": "HIGH"}], "browseBranches": [{"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "BC17", "name": "Skin and Connective Tissue Diseases"}, {"abbrev": "BC04", "name": "Neoplasms"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}}, "hasResults": true}